Results 151 to 156 of about 1,266 (156)

1-deamino-8-d- arginine vasopressin (ddavp) normalized the bleeding time in patients with platelet disorder characterized by defective calcium ionophore-induced platelet aggregation

British Journal of Haematology, 2003
Ichiro Fuse, Wataru Higuchi
exaly  

Effect of 1-deamino 8-d-arginine vasopressin spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis

International Journal of Pediatric Otorhinolaryngology, 2006
Sadik Gorur, Esin Atik, Semsettin Okuyucu   +2 more
exaly  

Absorption of a vasopressin analogue, 1-deamino-8-d-arginine-vasopressin (dDAVP), in a human intestinal epithelial cell line, CaCO-2

International Journal of Pharmaceutics, 1990
Per Artursson
exaly  

Normal Response of Factor VIII and von Willebrand Factor to 1-Deamino-8d-Arginine Vasopressin in Nephrogenic Diabetes Insipidus

Journal of Clinical Endocrinology and Metabolism, 1988
U Seligsohn, Z Hochberg, Brenner B
exaly  

Improving 1-Deamino-8-D-Arginine Vasopressin (DDAVP) Challenges in Pediatric/Young Adult Patients With Bleeding Disorders: A Quality Improvement Study

Journal of Pediatric Hematology/Oncology Nursing
Amy L Dunn, Vilmarie Rodríguez
exaly  

Development of the Schwartz-Bartter syndrome after the administration of chlorpropamide and 1-deamino-8-D-arginine vasopressin. [PDF]

Endokrinologie, 1982
Valkusz Zsuzsanna, Laczi F., László Ferenc   +2 more
openaire   +1 more source